Can COVID-19 cause white patches on the tonsils?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

COVID-19 Does Not Typically Cause White Patches on Tonsils

White patches on the tonsils are not a characteristic manifestation of COVID-19 infection. While COVID-19 can cause various oral manifestations, the documented presentations differ significantly from the classic white tonsillar exudates seen in bacterial pharyngitis.

What COVID-19 Actually Causes in the Oral Cavity

The documented oral manifestations of COVID-19 include 1:

  • Ulcers and erosions (most common)
  • Vesicles and bullae
  • Erythema and petechiae
  • Tongue changes (depapillated, fissured, or geographic tongue)
  • Hemorrhagic lesions
  • Taste disturbances (dysgeusia)

The most commonly affected sites are the tongue (38%), labial mucosa (26%), and palate (22%) 1. Notably, white patches or exudates on tonsils are not listed among the recognized COVID-19 oral manifestations.

Important Clinical Context

Tonsillar Involvement in COVID-19

While SARS-CoV-2 can infect tonsillar tissue—particularly in children where the virus can persist in palatine tonsils and adenoids even without symptoms 2—this infection does not produce the white exudative patches characteristic of bacterial tonsillitis. The viral presence in tonsils involves lymphoid cells (particularly CD20+ B lymphocytes) and epithelial surfaces 2, but manifests differently than bacterial infections.

What the White Patches Likely Represent

If you observe white patches on tonsils in a patient with COVID-19, consider:

  1. Bacterial co-infection (most likely Streptococcus pyogenes)
  2. Secondary opportunistic infections such as candidiasis 3
  3. Concurrent but unrelated bacterial pharyngitis

The oral lesions specifically associated with COVID-19 include candidiasis (appearing as whitish areas), but this presents differently from tonsillar exudates and is considered a secondary manifestation resulting from immunosuppression, stress, or deterioration of systemic health rather than direct viral pathology 3.

Clinical Pitfalls to Avoid

Do not assume white tonsillar patches are from COVID-19 alone. The documented oral manifestations of COVID-19 are predominantly inflammatory, ulcerative, or vascular in nature 1, 4. When white patches appear on tonsils in COVID-19 patients, they likely represent:

  • Bacterial superinfection requiring antibiotic therapy
  • Fungal overgrowth (candidiasis) from immunosuppression
  • A separate concurrent infection

The presence of white tonsillar exudates should prompt evaluation for bacterial pharyngitis (rapid strep test, throat culture) or candidiasis, particularly in patients receiving corticosteroids or other immunosuppressive treatments for COVID-19.

References

Research

Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020

Research

Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry, 2020

Related Questions

What is the recommended treatment for a COVID-19 positive patient presenting with back pain and lower-leg myalgia without fever?
How should I manage a 75-year-old man with a 4‑day history of generalized body aches and weakness, negative for streptococcal infection, influenza, and COVID‑19, no upper respiratory infection, and who is taking atorvastatin, allopurinol, lisinopril, and meloxicam?
What is the appropriate outpatient management for a clinically stable 11‑month‑old infant with acute COVID‑19?
What is the appropriate workup and management for a patient who has lost 60 lb (≈27 kg) over the past 18 months after COVID‑19 infection and now presents with bradycardia and resting oxygen saturation of 88‑92 %?
What is the likely diagnosis and recommended treatment for a 53-year-old woman with acute bilateral anterior leg dysesthesia resembling cold water sensation that started one hour ago during a walk, with no recent injury and a COVID-19 infection two weeks ago?
What should I do if I take two 112 µg levothyroxine tablets four hours apart on the same day?
How many Basaglar (insulin glargine) U‑100 pens are required for a daily dose of 10 units?
Can semaglutide be used in an adult patient with chronic kidney disease who does not have diabetes?
What oral medication can be prescribed to reduce pain and facilitate cervical softening for intrauterine device (IUD) insertion?
What is the appropriate fibrinogen replacement dose after therapeutic plasma exchange?
What are the signs and symptoms of pembrolizumab-related pneumonitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.